Physician

Oncology

Dr. Christopher T. Stokoe, MD

Christopher T. Stokoe practices Oncology. He received 1 awards: "Meaningful Use Stage 1 Certification". Christopher Stokoe is a published doctor. He has 1 publication published. The most current publication "Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2-amplified early stage breast cancer: a single-group, open-label, phase 2 study." Christopher T. Stokoe accepts Medicare.

Publications

Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2-amplified early stage breast Cancer: a single-group, open-label, phase 2 study.

Schools

University of Texas Medical Branch
Baylor University Medical Center

Procedures Preformed

Thoracentesis

Conditions Treated

Acute Leukemia
Adrenal Gland Cancer
Anal and Rectal Cancer
Anemia
View All

Doctors Specialties

Oncology

Accepted Insurances

Awards

Meaningful Use Stage 1 Certification

Education

Baylor University Medical Center
University of Texas Medical Branch

Drug Facts

NPI NUMBER		1801839758
NPPES Provider LastName		STOKOE
NPPES Provider FirstName		CHRISTOPHER
NPPES Provider ZIPCode		750757753
NPPES Provider State		TX
Specialty Description		Medical Oncology
Total Claim Count		1434.0
Distinct Opioid Count		5.0
Opioid Claim Count		148.0
Percent Opioid Claims		10.32

Helpful Reviews

Give Anonymous Review

Medicare Facts

National Provider Identifier [NPI]	1801839758
Last Name Of The Provider	STOKOE
First Name Of The Provider	CHRISTOPHER
View All

Similar Doctors

	Dr. Gerardo H. Trillo, MD This Doctor is OpenDoctor Recommended.
	Dr. Robert L. Kirby, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Charles K. Connor, MD This Doctor is OpenDoctor Recommended.
	Dr. Ruben A. Saez, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Virginia M. Kinsella, MD This Doctor is OpenDoctor Recommended.